Anvisa alerta para risco raro de perda de visão associado ao Ozempic

[{"selector":"#anim-1537241f-8802-4373-a201-01440a6edd31","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2b461764-a700-4ef4-b710-9196af4e2b5a","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5cddcd6d-5d84-4282-a1e5-1d604f1257d2","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-c1936b47-9d95-4aa5-bd8e-ccbefa102654","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Pexels

[{"selector":"#anim-397063f6-dee4-463f-97cb-90e462b36106","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a7a63aec-d643-4622-874a-383660d155b2","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-ca2cd4df-de60-4eee-95a4-eb890a572e7d","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-b81c74da-94c1-439b-a6a5-6d41e0b9f3e3","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] A Anvisa emitiu um alerta sobre um evento adverso muito raro que pode causar perda de visão repentina relacionada ao uso de medicamentos com semaglutida , é o caso do Ozempic, Rybelsus e Wegovy, todos da farmacêutica Novo Nordisk imyskin/GettyImages

[{"selector":"#anim-41752640-e8a1-4e0a-8d7d-daeab79c8856","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-266d3ec5-f1a4-45bc-a26b-e20ed47d3261","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-e898ccae-6115-42c2-9eb2-2f7db113db37","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-84a55d18-6104-4020-b445-8ccf292e2c6c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Além do alerta, a Anvisa solicitou a inclusão da reação adversa chamada neuropatia óptica isquêmica anterior não arterítica (Noiana) nas bulas desses medicamentos Pexels

[{"selector":"#anim-bf270710-5bdc-4a57-9755-1d61e40303f7","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e2706362-6f2a-48fa-8844-f096a94b5076","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-56075bac-16a8-4fe9-95d5-6ee39bd26e8a","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-c7e4a0a2-0358-4757-94dd-a9d84f187237","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] A decisão foi tomada após análises do Comitê de Avaliação de Risco em Farmacovigilância (PRAC) da Agência Europeia de Medicamentos (EMA), que identificou a Noiana como um possível evento adverso da semaglutida Pexels

[{"selector":"#anim-92dcd9c6-0d5f-475d-b739-af437e029eb4","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f5c66eec-a99d-4fbb-b531-060b8a63f0a7","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-58a73e65-9975-4c53-83a3-420524968e02","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-fd4160e2-64f8-47e1-ac03-e2499d2608d6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] A Noian a é uma lesão do nervo óptico que ocorre devido a uma obstrução do suprimento de sangue, causando a disfunção das células do nervo óptico e perda de visão Pexels

[{"selector":"#anim-73803fbd-bc51-41aa-b345-71fd7f1bec57","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-72a7b3d8-ce99-4e37-8d7d-1853dd6fb7d1","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-62127f91-44dc-43dd-a6d3-27e5ebf6a0f4","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-fa4006b8-dd78-4b4d-b965-c2297c3cb322","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Segundo o Manual MSD , a perda de visão decorrente da Noiana é rápida, mas indolor, e, geralmente, fica restrita a um olho Pexels

[{"selector":"#anim-695e7b36-466e-4b1e-ade0-bd0ee630db94","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-829d1aac-660c-41a0-a14a-c2f41da657c9","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5705e0ba-e7a6-41c6-ae74-b3104f27dad6","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-81110c45-bed8-483f-9aa8-96a872700008","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] No início do ano, dois estudos dinamarqueses mostraram que pessoas que tratam diabetes tipo 2 com Ozempic têm risco aumentado de desenvolver danos ao nervo óptico do olho , podendo levar à perda grave e permanente da visão Pexels

CNNBRASIL.COM.BR

[{"selector":"#anim-f50a5896-36c7-4437-b1ff-d1e040767f8e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1ee021ad-a5ac-4588-8545-fe12af839fe6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-15d5b0ba-5903-440d-ad63-bc08160cef74","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0aa43550-1c01-4ebb-bfbd-111286cb6c2f","keyframes":{"transform":["translate3d(0px, 1483.57597%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d27a75ea-da74-4fbd-8cb9-5fee1a9c60c8","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a73573a9-a624-4569-aff3-76b3ba8d2c1b","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5708ccd6-2888-4d31-9b7e-51f8c721516e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-24e4adcd-17e5-400a-a5c2-a213b570cada","keyframes":{"transform":["translate3d(0px, 870.06218%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Pexels leia mais em